Mead sale no bellwether for startups (Dealscape

Mead Johnson Nutrition Co. went public successfully Wednesday, but it is still far too early for venture-backed startups and their exit-minded investors to start celebrating a return of the IPO market.

The Evansville, Ind., infant formula company, still 85% owned by parent Bristol-Myers Squibb Co. of New York, priced at the top of its expected range and saw shares rise in its first day of trading. But the outlook for the initial public offering market, crucial to the financial health of biotech and high-tech startup firms, is no better than before.

This is a free preview of the content available in The Deal Pipeline. Subscribers enjoy access to the full story, as well as second-to-none research tools.

To request a demo, or, if you are an existing user to The Deal Pipeline, log in to your account, please scroll down and click the button.

Dig deeper, with Pipeline.

503 articles related to Bristol-Myers Squibb Co.
25 company pages related to Nutrition
19 articles related to Mead Johnson Nutrition Co.
14 in-depth records of recent IPO activity
10 years of news and analysis archives from the voice of The Deal Economy

Most searched keywords

Skadden Arps
Amusement parks
Deb Shops
Windstream Corp.
Diedrich Coffee
Hanna Andersson
Tween Brands
Entertainment
Lazard
Lyondell Chemical

Forward-looking intelligence allows you time to act. View this video on our restructuring content to see how you can benefit from our expertise.
NOT A SUBSCRIBER? Mead sale no bellwether for startups Posted on February 12, 2009 9:36 AM Mead Johnson Nutrition Co. went public successfully Wednesday, but it is still far too early for venture-backed startups and their exit-minded investors to start celebrating a return of the IPO market. The Evansville, Ind., infant formula company, still 85% owned by parent Bristol-Myers Squibb Co. of New York, priced at the top of its expected range and saw shares rise in its first day of trading. But the outlook for the initial public offering market, crucial to the financial health of biotech and high-tech startup firms, is no better than before. This is a free preview of the content available in The Deal Pipeline. Subscribers enjoy access to the full story, as well as second-to-none research tools. To request a demo, or, if you are an existing user to The Deal Pipeline, log in to your account, please scroll down and click the button. Dig deeper, with Pipeline. 503 articles related to Bristol-Myers Squibb Co. 25 company pages related to Nutrition 19 articles related to Mead Johnson Nutrition Co. 14 in-depth records of recent IPO activity 10 years of news and analysis archives from the voice of The Deal Economy Most searched keywords Skadden Arps Amusement parks Deb Shops Windstream Corp. Diedrich Coffee Hanna Andersson Tween Brands Entertainment Lazard Lyondell Chemical		EXISTING USERS Username Password Forget your password? Missing a product?

Sales Contact Michael Crosby mcrosby@thedeal.com 212.313.9325	Media Contact Martha Brown mbrown@thedeal.com 212.313.9218
Signing in signifies that you agree to our terms and conditions. View our privacy policy.